Literature DB >> 7153395

Nonantibiotic approach in control of bovine mastitis during dry period.

S P Oliver, K L Smith.   

Abstract

Twenty cows were used to determine effectiveness of a nonantibiotic method for control of intramammary infection during the dry period. Right mammary quarters of cows were infused with colchicine, endotoxin, or both at 1 day prior to or at the end of lactation. Left quarters were uninfused controls within group. Samples (n = 1105) of foremilk were obtained aseptically from quarters for bacteriological analysis. Quarters were sampled during the last week of lactation, early nonlactating period, prepartum, at parturition, and 1 and 2 wk postpartum. Primary pathogens isolated were esculin + streptococci, coagulase + staphylococci, and coliform bacteria. Isolation of primary pathogens was reduced 50% in right infused quarters during the 1st wk of involution as compared to left uninfused quarters. Thirteen of 80 quarters were infected at the end of lactation (6 right and 7 left), and 20 of 80 quarters (9 right and 11 left) were infected at calving. Sixteen of the 20 infections at calving were new during the dry period. Treatment reduced infection during early involution but failed to prevent new infection during the remainder of the dry period.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7153395     DOI: 10.3168/jds.S0022-0302(82)82470-3

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  2 in total

1.  The effect of a single intramammary infusion of a biological response modifier in cows at drying off.

Authors:  Bibiana Elisabet Dallard; H H Ortega; I A Iguzquiza; N R Salvetti; O A Quaino; L F Calvinho
Journal:  Vet Res Commun       Date:  2010-07-02       Impact factor: 2.459

2.  An evaluation of casein hydrolyzate in combination with antibiotic for bacterial cure and subsequent increase in milk yield in dairy cows.

Authors:  Gabriel Leitner; Shamay Jacoby; Nissim Silanikove
Journal:  BMC Vet Res       Date:  2011-01-07       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.